Recognition of central nervous system leukemia by flow cytometry

Area of Science:

• Hematology
• Oncology
• Neuroscience

Background:

• Central nervous system (CNS) involvement is a critical complication in acute leukemia.
• Accurate detection of leukemic cells in cerebrospinal fluid (CSF) is essential for timely diagnosis and treatment.
• Traditional cytological examination of CSF may have limitations in identifying all cases of CNS leukemia.

Purpose of the Study:

• To evaluate the utility of DNA/RNA flow cytometry in detecting leukemic cells in the cerebrospinal fluid of patients with acute leukemia.
• To compare the sensitivity of DNA/RNA flow cytometry with cytological criteria for identifying CNS leukemia.
• To assess the ability of DNA/RNA flow cytometry to differentiate between lymphoblastic and non-lymphoblastic leukemia subtypes in CSF.

Main Methods:

• Cerebrospinal fluid samples from 24 patients with acute leukemia were analyzed using DNA/RNA flow cytometry.
• Flow cytometry assessed DNA stemlines (ploidy) and RNA content for cellular characterization.
• Results were compared with cytological morphology findings.

Main Results:

• Abnormal DNA stemlines (aneuploidy) were detected in 6 of 15 patients with CNS relapse.
• Leukemic cells were identified by high RNA content in two additional cases.
• DNA/RNA flow cytometry detected leukemic cells missed by cytology in 5 out of 6 patients.
• The method differentiated lymphoblastic (low RNA) from non-lymphoblastic (high RNA) leukemia.

Conclusions:

• DNA/RNA flow cytometry is a sensitive tool for detecting leukemic infiltration in the CNS.
• This technique improves the identification of leukemia in CSF compared to conventional cytology.
• DNA/RNA flow cytometry aids in characterizing leukemia subtypes and monitoring disease progression in the CNS.